MK
Therapeutic Areas
Bantam Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| BTM-3566 | Mature B-cell Lymphomas (DLBCL, MCL, FL) | Pre-clinical |
Leadership Team at Bantam Pharmaceutical
MS
Michael Stocum, MS
President & CEO
GW
Glen Weiss, MD, MBA
Chief Medical Officer
BM
Briggs Morrison, MD, PhD
Scientific Advisor